Connect with us

News

Sputnik V COVID-19 Vaccine To Be Rolled Out Across Apollo Hospitals, Will Cost Rs. 1,195 Per Dose

India and Russia are planning to manufacture around 35-40 million COVID-19 vaccine doses every month that will start from August or September

Sputnik V COVID-19 Vaccine To Be Rolled Out Across Apollo Hospitals, Will Cost Rs. 1,195 Per Dose
Highlights
  • Apollo Hospitals will administer Sputnik V from the second week of June
  • The vaccine will cost Rs 995 plus Rs 200 would be administration charges
  • Sputnik V is the third vaccine to get emergency use license in India

New Delhi: Apollo Group of Hospitals has announced that it will start administering the Russian COVID-19 vaccine Sputnik V, across its hospitals in India from the second week of June, at an estimated price of Rs 1,195 per dose. “We will be charging Rs 995 for the vaccine and Rs 200 would be administration charges,” an official of the Apollo Group said. On Thursday (May 27), Apollo Hospitals said they will start administering Sputnik V from the second week of June.

Also Read: Sputnik V, The Third Approved COVID-19 Vaccine Launched In India, To Cost Rs.995.4 Per Shot

In a statement, Executive Vice-chairperson Shobana Kamineni of the Apollo Group of Hospitals said that the group has completed administering one million vaccine doses across 80 locations in India, and will prioritise frontline workers, high-risk population, and corporate employees. Giving details on ramping up their vaccination programme, Kamineni said,

In June, we will do a million every week and double that in July. We are on track to complete 20 million jabs by September this year.

India is moving towards vaccine sufficiency as inoculations with the Russian vaccine Sputnik V began in the country earlier this month. As reported earlier, India and Russia are planning to manufacture around 35-40 million doses every month that will start from August or September. On May 24, the Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, had launched the production of the Sputnik V Covid-19 vaccine. Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third COVID-19 vaccine to get clearance in India. India has become the 60th country to authorise the use of the Russian vaccine against coronavirus.

Also Read: India Should Be Able To Fully Vaccinate 60 Crore People Against COVID-19 By December: Dr Naresh Trehan

It is now approved in countries with a total population of 3 billion, or 40 percent of the world’s population. Under the Centre’s liberalised vaccination policy, the private sector hospitals have earned a crucial role as they can directly procure the doses from manufacturers and administer them to the eligible beneficiaries. The beneficiaries, however, need to register themselves for the jabs through the CoWin platform. Sputnik V was registered in India under emergency use authorization procedure on April 12 and vaccination against coronavirus with the Russian vaccine started on May 14. Earlier, while highlighting the Sputnik V progress, deputy chief of mission Roman Babushkin, told ANI,

Sputnik V is one of the vaccines which is included in the Indian mass vaccination drive and it speaks for itself. This company (Panacea Biotec) is one of the Indian partners which the Russian Direct Investment Fund and is developing a business partnership. The preliminary schedule is gradually is to reach 850 million doses in India per year. We know that there is interest from other business partners and even state governments, all these proposals we are studying very carefully.

Talking about the status of the single-dose vaccine ‘Sputnik lite’, the Russian envoy had said promotion in India and distribution would be very helpful.

Also Read: Explainer: How Worried Should We Be About Blood Clots Linked To Astrazeneca, Johnson And Johnson Vaccines?

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Click to comment

Leave a Reply

Your email address will not be published.

Highlights Of The 12-Hour Telethon

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पड़े

Folk Music For A Swasth India

RajasthanDay” src=